Holen Sie sich die Stockscreener-App
25.80
0.08%
0.0201
Schlusskurs vom Vortag:
$25.78
Offen:
$25.82
24-Stunden-Volumen:
608
Relative Volume:
0.16
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.72%
1M Leistung:
-2.81%
6M Leistung:
-2.75%
1J Leistung:
-2.71%
1-Tages-Spanne:
$25.80
$25.82
1-Wochen-Bereich:
$25.78
$26.09
52-Wochen-Spanne:
$25.00
$27.70
Cencora Inc Stock (CCOR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare CCOR vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CCOR
Cencora Inc
|
25.80 | 0 | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
881.51 | 102.78B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
321.57 | 61.36B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
234.57 | 54.56B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
88.36 | 9.85B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.8392 | 718.95M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Aktie (CCOR) Neueste Nachrichten
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga
Cencora (COR) ex-officer lines up new stock sale - Stock Titan
Cencora stock heads into the open after a 0.1% dip - ad-hoc-news.de
Cencora Inc. stock dips after RBC reiterates cautious price target - ad-hoc-news.de
Is Cencora Stock Underperforming the Dow? - inkl
Cencora stock heads into the open after a modest decline - ad-hoc-news.de
Cencora stock holds firm after RBC keeps $330 target - ad-hoc-news.de
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora stock price target maintained at $330 by RBC Capital - Investing.com Canada
Cencora, Inc. (COR) Stock Analysis: Robust Growth in Medical Distribution with an 11.59% Upside Potential - DirectorsTalk Interviews
Cencora Inc. stock gains on solid fiscal 2026 momentum - ad-hoc-news.de
Why Cencora (COR) Is Getting Attention Today - simplywall.st
Cencora stock gains on solid fiscal 2026 earnings momentum - AD HOC NEWS
Cencora’s New Cell and Gene Services Might Change The Case For Investing In Cencora (COR) - simplywall.st
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - finance.yahoo.com
Former Cencora (NYSE: COR) leader lines up another stock sale - Stock Titan
Cencora Inc. stock gains on new cell and gene therapy service and strong guidance - ad-hoc-news.de
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Cencora Launches Cell and Gene Therapy Enablement for Health Systems - finance.yahoo.com
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Yahoo Finance
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
What Cencora (COR)'s Cell and Gene Push and Higher 2026 Outlook Means For Shareholders - Yahoo Finance
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - finance.yahoo.com
Cencora Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs - BioBuzz
Artisan Sold Cencora (COR) as Earnings Momentum Slowed - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora (NYSE: COR) executive sells 985 shares in preset plan - Stock Titan
Cencora stock gains after guidance increase and resilient Q2 performance - AD HOC NEWS
Cencora Launches Cell and Gene Therapy Enablement Service Through Accelerate Pharmacy Solutions - marketscreener.com
Cencora Inc. stock reflects insider sale plans and steady growth outlook - AD HOC NEWS
Former Cencora (NYSE: COR) executive lines up stock sale after restricted shares vest - Stock Titan
Cencora, Inc. (COR) Stock Analysis: A Healthcare Powerhouse with 14.68% Potential Upside - DirectorsTalk Interviews
Cencora (COR) Q2 2026 Earnings Call Transcript - Fortune
Cencora Executive VP & Chief Legal Officer Elizabeth Campbell Sells 37% Of Holding - simplywall.st
Cencora (COR) Earnings History & Trends - 24/7 Wall St.
Elizabeth S Campbell Takes Money Off The Table, Sells $3.66M In Cencora Stock - Benzinga
Is Cencora (COR) Still Undervalued Following Its Board Resignation News? - Sahm
Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant With A 16% Upside Potential - DirectorsTalk Interviews
Paralel Advisors LLC Purchases New Position in Cencora, Inc. $COR - MarketBeat
Silvant Capital Management LLC Invests $11.93 Million in Cencora, Inc. $COR - MarketBeat
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Sahm
Fairtree Asset Management Pty Ltd Makes New $1.77 Million Investment in Cencora, Inc. $COR - MarketBeat
B. Metzler seel. Sohn & Co. AG Invests $9.62 Million in Cencora, Inc. $COR - MarketBeat
Algebris UK Ltd. Invests $969,000 in Cencora, Inc. $COR - MarketBeat
Cencora (NYSE:COR) Healthcare Growth Story Gains Fresh Momentum - Kalkine Media
Quartz Partners LLC Buys Shares of 15,650 Cencora, Inc. $COR - MarketBeat
United Bank Purchases New Stake in Cencora, Inc. $COR - MarketBeat
Shepherd Financial Partners LLC Takes Position in Cencora, Inc. $COR - MarketBeat
Meeder Advisory Services Inc. Purchases New Stake in Cencora, Inc. $COR - MarketBeat
Cencora (COR) Quarter in Focus: Profit Per Share Surpasses Its Benchmark for the Current Session; Latest Reaction: The Stock Ends Up 0.31% at the CloseGAAP Earnings Report - Vinanet
Finanzdaten der Cencora Inc-Aktie (CCOR)
Es liegen keine Finanzdaten für Cencora Inc (CCOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.65%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):